1. Ripley E.. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
Am Heart J 157(6 Suppl):2009;S7–S16.
2. Wheeler D.C., Becker G.J.. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?
Kidney Int 83:2013;377–383.
3. Hansen K.J., Tribble R.W., Reavis S.W., Canzanello V.J., Craven T.E., Plonk G.W. Jr, Dean R.H.. Renal duplex sonography: evaluation of clinical utility.
J Vasc Surg 12:1990;227–236.
4. Motew S.J., Cherr G.S., Craven T.E., Travis J.A., Wong J.M., Reavis S.W., Hansen K.J.. Renal duplex sonography: main renal artery versus hilar analysis.
J Vasc Surg 32:2000;462–471.
5. Darmon M., Schortgen F., Vargas F., Liazydi A., Schlemmer B., Brun-Buisson C., Brochard L.. Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients.
Intensive Care Med 37:2011;68–76.
6. Wan L., Yang N., Hiew C.Y., Schelleman A., Johnson L., May C., Bellomo R.. An assessment of the accuracy of renal blood flow estimation by Doppler ultrasound.
Intensive Care Med 34:2008;1503–1510.
7. Schnell D., Deruddre S., Harrois A., Pottecher J., Cosson C., Adoui N., Benhamou D., Vicaut E., Azoulay E., Duranteau J.. Renal resistive index better predicts the occurrence of acute kidney injury than cystatin C.
Shock 38:2012;592–597.
8. Radermacher J., Ellis S., Haller H.. Renal resistance index and progression of renal disease.
Hypertension 39:2002;699–703.
9. Onuigbo M.A., Onuigbo N.T.. Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients.
Int Urol Nephrol 40:2008;233–239.
10. Zierler R.E., Bergelin R.O., Isaacson J.A., Strandness D.E. Jr. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography.
J Vasc Surg 19:1994;250–257.
11. Tullis M.J., Zierler R.E., Caps M.T., Bergelin R.O., Cantwell-Gab K., Strandness D.E.. Clinical evidence of contralateral renal parenchymal injury in patients with unilateral atherosclerotic renal artery stenosis.
Ann Vasc Surg 12:1998;122–127.
12. Edwards M.S., Craven T.E., Burke G.L., Dean R.H., Hansen K.J.. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study.
Arch Intern Med 165:2005;207–213.
13. Edwards M.S., Hansen K.J., Craven T.E., Cherr G.S., Bleyer A.J., Burke G.L., Dean R.H.. Relationships between renovascular disease, blood pressure, and renal function in the elderly: a population-based study.
Am J Kidney Dis 41:2003;990–996.
14. Crutchley T.A., Pearce J.D., Craven T.E., Stafford J.M., Edwards M.S., Hansen K.J.. Clinical utility of the resistive index in atherosclerotic renovascular disease.
J Vasc Surg 49:2009;148–155.
15. Pozniak M.A., Kelcz F., Stratta R.J., Oberley T.D.. Extraneous factors affecting resistive index.
Invest Radiol 23:1988;899–904.
16. Mostbeck G.H., Gössinger H.D., MalIek A., Siostrzonek P., Schneider B., Tscholakoff D.. Effect of heart rate on Doppler measurements of resistive index in renal arteries.
Radiology 175:1990;511–513.
17. Suissa S., Hutchinson T., Brophy J.M., Kezouh A.. ACE-inhibitor use and the long-term risk of renal failure in diabetes.
Kidney Int 69:2006;913–919.
18. Ahmed A.K., Kamath N.S., El Kossi M., El Nahas A.M.. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
Nephrol Dial Transplant 25:2010;3977–3982.